The Marque The Marque
The Marque
About Services Profiles Press Contact

Jim Mellon

Founder and Executive Chairman

Burnbrae Group

Douglas, IM

Jim Mellon
Karen Mehiel
Kampack Inc
Michael Mendes
Just Desserts

Jim’s Biography

Jim Mellon is a British entrepreneur, investor and philanthropist with a broad range of financial interests. Through the company he founded in 1994, the Burnbrae Group, Jim has a diverse portfolio of investments in private and public companies, as well as significant real estate holdings in Germany and the Isle of Man.

Jim’s core investment principles and beliefs are the result of meticulous research and analysis of nascent industries or extensive changes in markets. He has frequently predicted emerging market trends and identified global industry developments at an early stage. In his book ‘Wake Up!’ he famously foresaw the financial crash of 2008.

His 2017 book ‘Juvenescence' sparked a rush of capital into the expanding field of aging research, resulting in the formation of Juvenescence, a cutting-edge biopharmaceutical business focused on the commercialisation of therapies to delay, stop, and reverse aging.

Most recently, Jim wrote ‘Moo’s Law’, a book that focuses on investment opportunities in cellular agriculture and the new agrarian revolution. Jim co-founded Agronomics...
Jim Mellon is a British entrepreneur, investor and philanthropist with a broad range of financial interests. Through the company he founded in 1994, the Burnbrae Group, Jim has a diverse portfolio of investments in private and public companies, as well as significant real estate holdings in Germany and the Isle of Man.

Jim’s core investment principles and beliefs are the result of meticulous research and analysis of nascent industries or extensive changes in markets. He has frequently predicted emerging market trends and identified global industry developments at an early stage. In his book ‘Wake Up!’ he famously foresaw the financial crash of 2008.

His 2017 book ‘Juvenescence' sparked a rush of capital into the expanding field of aging research, resulting in the formation of Juvenescence, a cutting-edge biopharmaceutical business focused on the commercialisation of therapies to delay, stop, and reverse aging.

Most recently, Jim wrote ‘Moo’s Law’, a book that focuses on investment opportunities in cellular agriculture and the new agrarian revolution. Jim co-founded Agronomics Ltd. in order to invest in companies leading the way in this sphere, and is its largest investor.

Jim is a member of the Board of Trustees of the American Federation for Aging Research (AFAR), the Buck Institute for Research on Aging and the Biogerontology Research Foundation. He is an Honorary Fellow of Oxford University's Oriel College, where he has founded the Mellon Centre for Longevity. Jim also sits on the Advisory Board of the Center for the Future of Aging, part of the Milken Institute.
moreless

Jim’s Newsfeed

Edison Investment Research
At the forefront of a new agrarian revolution

Entrepreneur and investor Jim Mellon co-founded Agronomics (ANIC) in 2019.

View News Archive

Jim’s Background

Burnbrae Group
Founder and Executive Chairman
Jan 1990 - Present
Douglas, IM
The Burnbrae Group is a global investment company headquartered on the Isle of Man and focused on identifiable emerging trends. The company invests in the financial services, information technology, leisure, property, life sciences and mining sectors.
Juvenescence
Co-founder and Chairman
Oct 2016 - Present
Juvenescence is a biotech company that has brought together a coalition of the best and most experienced scientists, drug developers, physicians, and investors to create cutting-edge therapies and products to improve the way we age. The company works closely with researchers worldwide and aims to empower people to plan their life journey and live longer.
View allHide

Jim’s Gallery

Board Positions

SalvaRx Group PLC
Board Member and Chairman
Jun 2015 - Present
SalvaRx Group is a pharmaceutical development company. Their focus is the development of effective pharmaceuticals for oncology patients. The company was previously known as 3legs Resources PLC.
Charlemagne Capital
Board member
Mar 2006 - Present
Charlemagne Capital was acquired by Fiera Capital in 2018. Jim also serves as Board member at Charlemagne Capital UK Ltd and Charlemagne Capital Iom Ltd.
View allHide

Advisory Roles

Milken Institute
Advisory Board Member, Center for the Future of Aging
Santa Monica, CA, USA
The Milken Institute is a non-profit global organization that supports people to build meaningful and healthy lives, in which they can access effective education and gainful employment whilst developing and contributing to their broader communities.

Other Business Interests

AgeX Therapeutics
Investor
Alameda, CA, USA
AgeX Therapeutics is a biotechnology company focused on the development of innovative medicines and the commercialization of newly emerging therapeutics targeting human aging.

Current Board Positions

Agronomics Limited
Co-Founder and Non-Executive Director
Apr 2019 - Present
Douglas, IM
Agronomics Limited is investment vehicle taking stakes in companies pioneering alternatives to meat and fish. The idea is to grow meat cleanly from cells and to avoid all the environmental and animal welfare consequences of traditional meat production.
Webis Holdings PLC
Non-Executive Director
Jan 2012 - Present
Douglas, IM
Webis Holdings PLC is a holding company with subsidiaries functioning in the global gaming and technology sectors.
View allHide

Previous Board Positions

Portage Biotech
Non-Executive Director
Toronto, CA
Portage Biotech (NASDAQ: PRTG) is a clinical-stage immuno-oncology company dedicated to revolutionising research into cancer and the development of world-leading treatments that contribute significantly in helping cancer patients improve their quality of life.
FastForward Innovations Limited
Executive Co-Chairman
Saint Peter Port, GG
FastForward Innovations Limited's investment focus is on emerging, problem-solving, innovative technologies that will determine the future.
View allHide

Media

New Alternatives to Animal Protein
Panel discussion
Dec 2021
At the Bloomberg Technology Summit, Jim Mellon spoke to Senior Editor, Anne Riley Moffat, about new alternatives to animal protein.
The Longevity Forum: An Agricultural Revolution To Save Our World
Video
Nov 2021
In 2021 The Longevity Forum took place in Glasgow during the COP26 climate summit. This panel session on the future of food and agriculture was moderated by the forum’s co-founder Jim Mellon and included Cassandra Coburn, Editor in Chief The Lancet; Henry Dimbleby Co-founder Leon Restaurants; and Eugene Klerk Head of Global ESG Credit Suisse.
View allHide

Interviews

Jim Mellon predicts the end of animal and dairy farming
Interviewee
Jul 2021
In this video Jim talks to Euronews about the prospect of an agrian revoultion, and how we can all be healthier for longer.

Publications

Moo's Law
Author
Dec 2020
Petersfield, UK
Jim has written Moo’s Law to help readers understand the landscape of investment in cultivated or plant-based proteins. He anticipates that global agriculture will be completely transformed by the growth of the cultivated meat technology industry over the next twenty years.
Juvenescence: Investing in the Age of Longevity
Author
Sep 2017
Sudbury, UK
In this book, co-authors Jim Mellon and Al Chalabi present a roadmap to longevity, analysing the latest technologies available and describing how to benefit from them.
View allHide

Memberships

Longevity Biotechnology Association
Founding Member
Nov 2021 - Present
Formed in 2021, the Longevity Biotechnology Association brings together leaders in gerotherapeutics and geroscience with the aim of developing therapies and medicines to extend healthspan and end age-related diseases.

Awards & Endorsements

American Federation for Aging Research
George E. and Marie J. Doty Award
New York, NY, USA
The American Federation for Aging Research has the provision of funding for biomedical research on aging at the heart of its mission. Jim was given the George E. and Marie J. Doty Award for his contribution to aging research.

Academic Appointments

Oriel College, University of Oxford
Honorary Fellow
Oxford, UK
Jim is an alumni of Oriel College, the fifth oldest of the University of Oxford’s colleges. Oriel was founded in 1326.

Speaking Engagements

Master Investor
Speaker, Master Investor Show 2019
Apr 2019
Jim presents on the main stage at the 2019 Master Investor Show. He offers the audience his perspective on market developments and thematic economic trends.

Charitable Interests

Lifeboat Foundation
Board member
Reno, NV, USA
The Lifeboat Foundation is a non-profit and non-governmental organization committed to promising scientific developments.

Jim’s Education

Oriel College, University of Oxford
Master's in Politics, Philosophy and Economics (PPE)
1976 - 1979